Collectively, these findings indicate that AIM2, RIG-I and NLRP3 inflammasomes in tumour cells are activated by factors from the viral and tumour microenvironments, thus contributing to IL-1β secretion. The gene discussed is NLRP3; the disease is neoplasm.